跳至主要内容
临床试验/NCT01601327
NCT01601327已完成4 期

Effects of Three Different Medications on Metabolic Parameters and Testicular Volume in Patients With Hypogonadotropic Hypogonadism-Last Three Years Experience

Gulhane School of Medicine2 个研究点 分布在 1 个国家目标入组 119 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
119
试验地点
2
主要终点
Effects of testosterone enanthate and testosterone gel on BMI, haemoglobin, haematocrit, urea creatinine, triglyceride, total testosterone (TT) and HDL-cholesterol were measured.

研究概览

简要总结

The aim of the present study was to demonstrate the influences of three different treatment strategies on biochemical parameters and testicular volume (TV) in patients with idiopathic hypogonadotropic hypogonadism (IHH).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • hypogonadotropic hypogonadism
  • decreased serum testosterone concentration below the normal range (serum T < 300ng/dL),
  • FSH and LH levels within or below the normal range,
  • absence of a pituitary or hypothalamic mass lesions on MRI, presence of gonadotropin response to repetitive doses of GnRH,
  • normal smell test and normal karyotypes

排除标准

  • previous androgen treatment,
  • history of smoking,
  • presence of bilateral anorchia,
  • intellectual deficiency,
  • diabetes mellitus,
  • arterial hypertension or dyslipoproteinemia,
  • medication of any kind and drug abuse. Because of possible confounding effects, patients with other hormone deficiencies were excluded.
  • Participants with iron, vitamin B12 or folate deficiency were also excluded.

研究组 & 干预措施

hypogonadism, treatment

Other

77 patients with idiopathic hypogonadotropic hypogonadism were treated with testosterone gel, testosterone enanthate or human chorionic gonadotropin

干预措施: Testosterone enanthate (Sustanon 250 mg) (Drug)

hypogonadism, treatment

Other

77 patients with idiopathic hypogonadotropic hypogonadism were treated with testosterone gel, testosterone enanthate or human chorionic gonadotropin

干预措施: Human chorionic gonadotropin (hCG) (Pregnyl 5000 IU) (Drug)

hypogonadism, treatment

Other

77 patients with idiopathic hypogonadotropic hypogonadism were treated with testosterone gel, testosterone enanthate or human chorionic gonadotropin

干预措施: Testosteron gel (Testojel 50 mg) (Drug)

Control group

No Intervention

42 healthy controls

干预措施: Testosterone enanthate (Sustanon 250 mg) (Drug)

结局指标

主要结局

Effects of testosterone enanthate and testosterone gel on BMI, haemoglobin, haematocrit, urea creatinine, triglyceride, total testosterone (TT) and HDL-cholesterol were measured.

时间窗: 3 years

Effects of testosterone gel on BMI, haemoglobin, haematocrit, urea creatinine, triglyceride, total testosterone (TT) and HDL-cholesterol were measured.

时间窗: 3 years

Effects of human chorionic gonadotrophin on BMI, haemoglobin, haematocrit, urea creatinine, triglyceride, total testosterone (TT) and HDL-cholesterol were measured.

时间窗: 3 years

次要结局

  • Effect of testosterone gel on testis volumes(3 years)
  • Effect of human chorionic gonadotrophin on testis volumes(3 years)
  • Effect of testosterone enanthate on testis volumes(3 years)

研究者

发起方
Gulhane School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aydogan Aydogdu

Principal Investigator

Gulhane School of Medicine

研究点 (2)

Loading locations...

相似试验